316 related articles for article (PubMed ID: 32669109)
1. Single-cell lineage analysis reveals genetic and epigenetic interplay in glioblastoma drug resistance.
Eyler CE; Matsunaga H; Hovestadt V; Vantine SJ; van Galen P; Bernstein BE
Genome Biol; 2020 Jul; 21(1):174. PubMed ID: 32669109
[TBL] [Abstract][Full Text] [Related]
2. The genomic landscape of response to EGFR blockade in colorectal cancer.
Bertotti A; Papp E; Jones S; Adleff V; Anagnostou V; Lupo B; Sausen M; Phallen J; Hruban CA; Tokheim C; Niknafs N; Nesselbush M; Lytle K; Sassi F; Cottino F; Migliardi G; Zanella ER; Ribero D; Russolillo N; Mellano A; Muratore A; Paraluppi G; Salizzoni M; Marsoni S; Kragh M; Lantto J; Cassingena A; Li QK; Karchin R; Scharpf R; Sartore-Bianchi A; Siena S; Diaz LA; Trusolino L; Velculescu VE
Nature; 2015 Oct; 526(7572):263-7. PubMed ID: 26416732
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
Kim JY; Gatenby RA
Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.
Szerlip NJ; Pedraza A; Chakravarty D; Azim M; McGuire J; Fang Y; Ozawa T; Holland EC; Huse JT; Jhanwar S; Leversha MA; Mikkelsen T; Brennan CW
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3041-6. PubMed ID: 22323597
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Epigenetic Modifications on Adaptive Resistance Evolution in Glioblastoma.
Wu Q; Berglund AE; Etame AB
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361090
[TBL] [Abstract][Full Text] [Related]
6. InsR/IGF1R Pathway Mediates Resistance to EGFR Inhibitors in Glioblastoma.
Ma Y; Tang N; Thompson RC; Mobley BC; Clark SW; Sarkaria JN; Wang J
Clin Cancer Res; 2016 Apr; 22(7):1767-76. PubMed ID: 26561558
[TBL] [Abstract][Full Text] [Related]
7. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.
Banelli B; Carra E; Barbieri F; Würth R; Parodi F; Pattarozzi A; Carosio R; Forlani A; Allemanni G; Marubbi D; Florio T; Daga A; Romani M
Cell Cycle; 2015; 14(21):3418-29. PubMed ID: 26566863
[TBL] [Abstract][Full Text] [Related]
8. Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma.
Wu H; Guo C; Wang C; Xu J; Zheng S; Duan J; Li Y; Bai H; Xu Q; Ning F; Wang F; Yang Q
Cancer Sci; 2023 Jun; 114(6):2609-2621. PubMed ID: 36853018
[TBL] [Abstract][Full Text] [Related]
9. Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity.
Meyer M; Reimand J; Lan X; Head R; Zhu X; Kushida M; Bayani J; Pressey JC; Lionel AC; Clarke ID; Cusimano M; Squire JA; Scherer SW; Bernstein M; Woodin MA; Bader GD; Dirks PB
Proc Natl Acad Sci U S A; 2015 Jan; 112(3):851-6. PubMed ID: 25561528
[TBL] [Abstract][Full Text] [Related]
10. PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.
Cenciarelli C; Marei HE; Zonfrillo M; Pierimarchi P; Paldino E; Casalbore P; Felsani A; Vescovi AL; Maira G; Mangiola A
Mol Cancer; 2014 Nov; 13():247. PubMed ID: 25380967
[TBL] [Abstract][Full Text] [Related]
11. Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma.
Reinartz R; Wang S; Kebir S; Silver DJ; Wieland A; Zheng T; Küpper M; Rauschenbach L; Fimmers R; Shepherd TM; Trageser D; Till A; Schäfer N; Glas M; Hillmer AM; Cichon S; Smith AA; Pietsch T; Liu Y; Reynolds BA; Yachnis A; Pincus DW; Simon M; Brüstle O; Steindler DA; Scheffler B
Clin Cancer Res; 2017 Jan; 23(2):562-574. PubMed ID: 27521447
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA.
Nathanson DA; Gini B; Mottahedeh J; Visnyei K; Koga T; Gomez G; Eskin A; Hwang K; Wang J; Masui K; Paucar A; Yang H; Ohashi M; Zhu S; Wykosky J; Reed R; Nelson SF; Cloughesy TF; James CD; Rao PN; Kornblum HI; Heath JR; Cavenee WK; Furnari FB; Mischel PS
Science; 2014 Jan; 343(6166):72-6. PubMed ID: 24310612
[TBL] [Abstract][Full Text] [Related]
13. Single-cell RNA sequencing reveals the impact of chromosomal instability on glioblastoma cancer stem cells.
Zhao Y; Carter R; Natarajan S; Varn FS; Compton DA; Gawad C; Cheng C; Godek KM
BMC Med Genomics; 2019 May; 12(1):79. PubMed ID: 31151460
[TBL] [Abstract][Full Text] [Related]
14. De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients.
Akhavan D; Pourzia AL; Nourian AA; Williams KJ; Nathanson D; Babic I; Villa GR; Tanaka K; Nael A; Yang H; Dang J; Vinters HV; Yong WH; Flagg M; Tamanoi F; Sasayama T; James CD; Kornblum HI; Cloughesy TF; Cavenee WK; Bensinger SJ; Mischel PS
Cancer Discov; 2013 May; 3(5):534-47. PubMed ID: 23533263
[TBL] [Abstract][Full Text] [Related]
15. Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells.
Fabro F; Kers TV; Feller KJ; Beerens C; Ntafoulis I; Idbaih A; Verreault M; Connor K; Biswas A; Salvucci M; Prehn JHM; Byrne AT; O'Farrell AC; Lambrechts D; Dilcan G; Lodi F; Arijs I; Kremer A; Tching Chi Yen R; Chien MP; Lamfers MLM; Leenstra S
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958662
[TBL] [Abstract][Full Text] [Related]
16. Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes.
Kessler T; Berberich A; Sadik A; Sahm F; Gorlia T; Meisner C; Hoffmann DC; Wick A; Kickingereder P; Rübmann P; Bendszus M; Opitz C; Weller M; van den Bent M; Stupp R; Winkler F; Brandes A; von Deimling A; Platten M; Wick W
Cancer Med; 2020 Nov; 9(22):8373-8385. PubMed ID: 32991787
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma.
Truffaux N; Philippe C; Paulsson J; Andreiuolo F; Guerrini-Rousseau L; Cornilleau G; Le Dret L; Richon C; Lacroix L; Puget S; Geoerger B; Vassal G; Östman A; Grill J
Neuro Oncol; 2015 Jul; 17(7):953-64. PubMed ID: 25534822
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma Stem Cells: Driving Resilience through Chaos.
Prager BC; Bhargava S; Mahadev V; Hubert CG; Rich JN
Trends Cancer; 2020 Mar; 6(3):223-235. PubMed ID: 32101725
[TBL] [Abstract][Full Text] [Related]
19. A Novel Receptor Tyrosine Kinase Switch Promotes Gastrointestinal Stromal Tumor Drug Resistance.
Boichuk S; Galembikova A; Dunaev P; Valeeva E; Shagimardanova E; Gusev O; Khaiboullina S
Molecules; 2017 Dec; 22(12):. PubMed ID: 29206199
[TBL] [Abstract][Full Text] [Related]
20. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.
Neftel C; Laffy J; Filbin MG; Hara T; Shore ME; Rahme GJ; Richman AR; Silverbush D; Shaw ML; Hebert CM; Dewitt J; Gritsch S; Perez EM; Gonzalez Castro LN; Lan X; Druck N; Rodman C; Dionne D; Kaplan A; Bertalan MS; Small J; Pelton K; Becker S; Bonal D; Nguyen QD; Servis RL; Fung JM; Mylvaganam R; Mayr L; Gojo J; Haberler C; Geyeregger R; Czech T; Slavc I; Nahed BV; Curry WT; Carter BS; Wakimoto H; Brastianos PK; Batchelor TT; Stemmer-Rachamimov A; Martinez-Lage M; Frosch MP; Stamenkovic I; Riggi N; Rheinbay E; Monje M; Rozenblatt-Rosen O; Cahill DP; Patel AP; Hunter T; Verma IM; Ligon KL; Louis DN; Regev A; Bernstein BE; Tirosh I; Suvà ML
Cell; 2019 Aug; 178(4):835-849.e21. PubMed ID: 31327527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
